1. bookVolumen 7 (2013): Heft 4 (August 2013)
Zeitschriftendaten
License
Format
Zeitschrift
eISSN
1875-855X
Erstveröffentlichung
01 Jun 2007
Erscheinungsweise
6 Hefte pro Jahr
Sprachen
Englisch
Uneingeschränkter Zugang

Brief communication (Original). Hyperandrogenemia is associated with thin endometrium in reproductive-aged Thai women with polycystic ovary syndrome

Online veröffentlicht: 04 Feb 2017
Volumen & Heft: Volumen 7 (2013) - Heft 4 (August 2013)
Seitenbereich: 545 - 551
Zeitschriftendaten
License
Format
Zeitschrift
eISSN
1875-855X
Erstveröffentlichung
01 Jun 2007
Erscheinungsweise
6 Hefte pro Jahr
Sprachen
Englisch

1. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005; 352:1223-36.10.1056/NEJMra041536Search in Google Scholar

2. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004; 19:41-7.10.1093/humrep/deh098Search in Google Scholar

3. Cheung AP. Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome. Obstet Gynecol. 2001; 98:325-31.Search in Google Scholar

4. Giudice LC. Endometrium in PCOS: implantation and predisposition to endocrine CA. Best Pract Res Clin Endocrinol Metab. 2006; 20:235-44.10.1016/j.beem.2006.03.005DOI öffnenSearch in Google Scholar

5. Iatrakis G, Tsionis C, Adonakis G, Stoikidou M, Anthouli-Anagnostopoulou F, Parava M, et al. Polycystic ovarian syndrome, insulin resistance and thickness of the endometrium. Eur J Obstet Gynecol Reprod Biol. 2006; 127:218-21.10.1016/j.ejogrb.2006.01.023Search in Google Scholar

6. Navaratnarajah R, Pillay OC, Hardiman P. Polycystic ovary syndrome and endometrial cancer. Semin Reprod Med. 2008; 26:62-71.10.1055/s-2007-992926DOI öffnenSearch in Google Scholar

7. Ozdemir S, Gorkemli H, Gezginc K, Ozdemir M, Kiyici A. Clinical and metabolic effects of medroxyprogesterone acetate and ethinyl estradiol plus drospirenone in women with polycystic ovary syndrome. Int J Gynaecol Obstet. 2008; 103:44-9.10.1016/j.ijgo.2008.05.017Search in Google Scholar

8. Gupta JK, Chien PF, Voit D, Clark TJ, Khan KS. Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis. Acta Obstet Gynecol Scand. 2002; 81:799-816.10.1034/j.1600-0412.2001.810902.xSearch in Google Scholar

9. Bennett GL, Andreotti RF, Lee SI, Dejesus Allison SO, Brown DL, Dubinsky T, et al. ACR appropriateness criteria on abnormal vaginal bleeding. J Am Coll Radiol. 2011; 8:460-8.10.1016/j.jacr.2011.03.011DOI öffnenSearch in Google Scholar

10. Wongwananuruk T, Indhavivadhana S, Rattanachaiyanont M, Techatraisak K, Leerasiri P, Tanmahasamut P, et al. Characteristics of 250 reproductive-aged polycystic ovary syndrome Thai women at Siriraj Hospital. J Med Assoc Thai. 2010; 93: 399-405.Search in Google Scholar

11. Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol. 1981; 140:815-30.10.1016/0002-9378(81)90746-8Search in Google Scholar

12. Speroff L, Fritz MA. Amenorrhea. In: Speroff L, Fritz MA, editors. Clinical Gynecologic Endocrinology and Infertility. 7th ed. Philadelphia: Lippincott Williams&Wikins; 2005.Search in Google Scholar

13. World Health Organization. Laboratory diagnosis and monitoring of diabetes mellitus. WHO 2002. Geneva:1-26.Search in Google Scholar

14. Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1998; 83:2694-8.10.1210/jc.83.8.2694Search in Google Scholar

15. Jensterle M, Weber M, Pfeifer M, Prezelj J, Pfutzner A, Janez A. Assessment of insulin resistance in young women with polycystic ovary syndrome. Int J Gynaecol Obstet. 2008; 102:137-40.10.1016/j.ijgo.2008.03.017Search in Google Scholar

16. Sengos C, Andreakos C, Iatrakis G. Sonographic parameters and hormonal status in lean and obese women with polycystic ovary syndrome. Clin Exp Obstet Gynecol. 2000; 27:35-8.Search in Google Scholar

17. Maiorano E, Loverro G, Viale G, Giannini T, Napoli A, Perlino E. Insulin-like growth factor-I expression in normal and diseased endometrium. Int J Cancer. 1999; 80:188-93.10.1002/(SICI)1097-0215(19990118)80:2<188::AID-IJC5>3.0.CO;2-ESearch in Google Scholar

18. Speroff L, Fritz MA. Hirsutism. In: Speroff L, Fritz MA, editors. Clinical Gynecologic Endocrinology and Infertility. 7th ed. Philadelphia: Lippincott Williams & Wikins; 2005.Search in Google Scholar

19. Allen NE, Key TJ, Dossus L, Rinaldi S, Cust A, Lukanova A, et al. Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer. 2008; 15:485-97.10.1677/ERC-07-0064DOI öffnenSearch in Google Scholar

20. Eliassen AH, Hankinson SE. Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies. Adv Exp Med Biol. 2008; 630:148-65.10.1007/978-0-387-78818-0_10Search in Google Scholar

21. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev. 2002; 11:1531-43.Search in Google Scholar

22. Lukanova A, Lundin E, Micheli A, Arslan A, Ferrari P, Rinaldi S, et al. Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int J Cancer. 2004; 108: 425-32.10.1002/ijc.11529Search in Google Scholar

23. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006; 91:4237-45.10.1210/jc.2006-0178Search in Google Scholar

Empfohlene Artikel von Trend MD

Planen Sie Ihre Fernkonferenz mit Scienceendo